9 Meters Biopharma Inc As Of Dec 31 Had Total Cash And Cash Equivalents Of About $29.7 Million

T-Reuters2023-03-28

9 Meters Biopharma Inc :As Of December 31, 2022, Had Total Cash And Cash Equivalents Of About $29.7 Million.Qtrly Net Loss Per Share Was $0.92.Q4 Earnings Per Share View $-0.76 -- Refinitiv Ibes Data.Expects Completion Of A Pre-Ind Meeting For Nm-136 Followed By Potential Ind Submission In The Second Half Of 2023.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment